Shasqi
Targeting Cancer with Click Chemistry
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Adjacent
Overlapping tags, a different niche.
AlixiaW22Targeting the Tumor Ecosystem to address cancer drug resistance.Shared: biotech, therapeuticsActive
Eris BiotechW24Our drugs engage the immune system to fight tumorsShared: biotech, therapeuticsActive
Guardian BioS22Dendritic cell-based platform for cancer therapyShared: biotech, therapeuticsActive
Adventris PharmaceuticalsW23Adventris makes cancer vaccinesShared: biotech, therapeuticsActive
Pardes BiosciencesS20We break virusesShared: biotech, therapeuticsPublic
Also from W15 in AI
Batchmates in Winter 2015.
20nW15Using AI to predict biochemistry for manufacturing and therapeuticsInactive
Numerion LabsW15Artificial intelligence for drug discovery.Active
Akido LabsW15Rebuilding healthcare with AI at the coreActive
BankjoyW15An end-to-end digital banking solution for banks and credit unionsActive
CyberFendW15Cyberfend delivers robust, real-time web and mobile security by…Acquired
DabbleW15A synthetic photo studio for e-commerceInactive
About Shasqi
Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two 'click', a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds.
San Francisco, CA, USA; Remote
Shasqi: questions
Which YC batch was Shasqi in?
Shasqi was in Y Combinator's Winter 2015 batch (W15).
Is Shasqi still active?
Y Combinator lists Shasqi as active.
Where is Shasqi based?
Shasqi lists San Francisco, CA, USA; Remote as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.